These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 9183809)
1. Effects of intrastriatal infusion of D2 receptor antisense oligonucleotide on apomorphine-induced behaviors in the rat. Rajakumar N; Laurier L; Niznik HB; Stoessl AJ Synapse; 1997 Jul; 26(3):199-208. PubMed ID: 9183809 [TBL] [Abstract][Full Text] [Related]
2. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development. Neal-Beliveau BS; Joyce JN Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220 [TBL] [Abstract][Full Text] [Related]
3. Dopamine transporter function assessed by antisense knockdown in the rat: protection from dopamine neurotoxicity. Van Kampen JM; McGeer EG; Stoessl AJ Synapse; 2000 Sep; 37(3):171-8. PubMed ID: 10881039 [TBL] [Abstract][Full Text] [Related]
4. [Behavioral effects of chronic apomorphine, and D-1/D-2 dopamine receptor activities in rats]. Minematsu N Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Jun; 15(3):247-52. PubMed ID: 7584718 [TBL] [Abstract][Full Text] [Related]
5. D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing Up-regulation of D2 dopamine receptors. Davidkova G; Zhou LW; Morabito M; Zhang SP; Weiss B J Pharmacol Exp Ther; 1998 Jun; 285(3):1187-96. PubMed ID: 9618422 [TBL] [Abstract][Full Text] [Related]
6. Intranigral administration of D2 dopamine receptor antisense oligodeoxynucleotides establishes a role for nigrostriatal D2 autoreceptors in the motor actions of cocaine. Silvia CP; King GR; Lee TH; Xue ZY; Caron MG; Ellinwood EH Mol Pharmacol; 1994 Jul; 46(1):51-7. PubMed ID: 8058056 [TBL] [Abstract][Full Text] [Related]
7. Ontogeny of apomorphine-induced stereotypy and its D1 and D2 receptor mediation in rats depleted of dopamine as neonates. Abrams DR; Bruno JP Dev Psychobiol; 1992 Nov; 25(7):475-95. PubMed ID: 1459343 [TBL] [Abstract][Full Text] [Related]
8. Dopamine D1 and D2 receptor-mediated acute and long-lasting behavioral effects of glial cell line-derived neurotrophic factor administered into the striatum. Kobayashi S; Ogren SO; Hoffer BJ; Olson L Exp Neurol; 1998 Dec; 154(2):302-14. PubMed ID: 9878169 [TBL] [Abstract][Full Text] [Related]
9. In vivo administration of an oligodeoxynucleotide antisense to the D2 dopamine receptor messenger RNA inhibits D2 dopamine receptor-mediated behavior and the expression of D2 dopamine receptors in mouse striatum. Zhou LW; Zhang SP; Qin ZH; Weiss B J Pharmacol Exp Ther; 1994 Feb; 268(2):1015-23. PubMed ID: 8113958 [TBL] [Abstract][Full Text] [Related]
10. Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat. Kimmel HL; Joyce AR; Carroll FI; Kuhar MJ J Pharmacol Exp Ther; 2001 Jul; 298(1):129-40. PubMed ID: 11408534 [TBL] [Abstract][Full Text] [Related]
12. The potential of high-resolution positron emission tomography to monitor striatal dopaminergic function in rat models of disease. Hume SP; Lammertsma AA; Myers R; Rajeswaran S; Bloomfield PM; Ashworth S; Fricker RA; Torres EM; Watson I; Jones T J Neurosci Methods; 1996 Aug; 67(2):103-12. PubMed ID: 8872875 [TBL] [Abstract][Full Text] [Related]
13. Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra. Hersch SM; Yi H; Heilman CJ; Edwards RH; Levey AI J Comp Neurol; 1997 Nov; 388(2):211-27. PubMed ID: 9368838 [TBL] [Abstract][Full Text] [Related]
14. D2 dopamine receptor antisense oligodeoxynucleotide inhibits the synthesis of a functional pool of D2 dopamine receptors. Qin ZH; Zhou LW; Zhang SP; Wang Y; Weiss B Mol Pharmacol; 1995 Oct; 48(4):730-7. PubMed ID: 7476901 [TBL] [Abstract][Full Text] [Related]
15. Dopamine receptor regulation of Ca2+ levels in individual isolated nerve terminals from rat striatum: comparison of presynaptic D1-like and D2-like receptors. Wu J; Dougherty JJ; Nichols RA J Neurochem; 2006 Jul; 98(2):481-94. PubMed ID: 16805841 [TBL] [Abstract][Full Text] [Related]
16. The role of dopamine D2 receptor in the behavioral effects of imipramine--study with the use of antisense oligonucleotides. Dziedzicka-Wasylewska M; Kolasiewicz W; Rogóz Z; Margas W; Maj J J Physiol Pharmacol; 2000 Sep; 51(3):401-9. PubMed ID: 11016860 [TBL] [Abstract][Full Text] [Related]
17. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists. McPherson RJ; Marshall JF Synapse; 2000 Jun; 36(3):194-204. PubMed ID: 10819899 [TBL] [Abstract][Full Text] [Related]
18. Effects of NMDA and MK-801 injected into the substantia nigra pars reticulata on jaw movements evoked by dopamine D1-/D2 receptor stimulation in the ventrolateral striatum: studies in freely moving rats. Uchida T; Lee J; Fujita S; Kiguchi M; Matsumoto M; Oi Y; Gionhaku N; Koshikawa N Methods Find Exp Clin Pharmacol; 2005; 27(1):31-7. PubMed ID: 15834457 [TBL] [Abstract][Full Text] [Related]
19. Failure of neuroprotection by embryonic striatal grafts in a double lesion rat model of striatonigral degeneration (multiple system atrophy). Puschban Z; Waldner R; Seppi K; Stefanova N; Humpel C; Scherfler C; Levivier M; Poewe W; Wenning GK Exp Neurol; 2000 Jul; 164(1):166-75. PubMed ID: 10877927 [TBL] [Abstract][Full Text] [Related]
20. Involvement of NMDA receptors in the ventrolateral striatum of rats in apomorphine-induced jaw movements. Fujita S; Kiguchi M; Kobayashi M; Koshikawa N; Waddington JL Brain Res; 2010 Mar; 1322():30-7. PubMed ID: 20122906 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]